drug
elasomeran
Marketedupdated 3mo agoby $MRNA Moderna, Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying elasomeran
- —Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGE
- phase3A Study of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults
- —Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran
- phase4COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2
News(1)
- Moderna maintains 10% growth target despite Phase 3 norovirus missModerna’s norovirus vaccine failed in a Phase 3 trial, but the company still has faith in an ambitious revenue growth target thanks to ex-U.S. vaccine sales and a unanimous FDA adcomm win for mFLUS…biospace · 14d ago
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that